CRT0066101 is a pan-PKD inhibitor that has been shown to reduce proliferation in a number of tumor types, including ER-negative breast cancer, pancreatic cancer, and colon cancer (62–65). This evidence concerns the gene PRKD1 and pancreatic neoplasm.